US1858602022 - CBLI - A14M47 (XNCM)
CLEVELAND BIOLABS INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 207,77 % |
Firmenprofil zu CLEVELAND BIOLABS INC Aktie
Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. The company is headquartered in Buffalo, New York and currently employs 15 full-time employees. The firm is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
Unternehmensdaten zur CLEVELAND BIOLABS INC Aktie
Name CLEVELAND BIOLABS INC
Firma Cytocom, Inc.
Symbol CBLI
Website http://www.cytocom.com
Heimatbörse
NASDAQ CAPITAL MARKET
WKN A14M47
ISIN US1858602022
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Yakov Kogan
Marktkapitalisierung 226 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 73 High St, Buffalo
IPO Datum 2006-07-21
Aktien-Splits
Datum | Split |
---|---|
28.01.2015 | 1:20 |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | CBLI |
Weitere Aktien
Investoren die CLEVELAND BIOLABS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024